Fig. 3From: Improved image reconstruction of 89Zr-immunoPET studies using a Bayesian penalized likelihood reconstruction algorithmScores for image quality and lesion detectability for a [89Zr]Zr-DFO-trastuzumab, b [89Zr]Zr-DFO-daratumumab, and c [89Zr]Zr-DFO-pertuzumab using OSEM reconstructions and Q.Clear BSREM with a β-value of 3600 for different fractions of original counts, applying a 5-point ordinal scaleBack to article page